US2466420A
(en)
|
1947-11-26 |
1949-04-05 |
Eastman Kodak Co |
Ketene condensation products with aldehydes
|
US3226394A
(en)
|
1964-06-16 |
1965-12-28 |
Shulton Inc |
Pyridylethylated anthranilamides and derivatives thereof
|
CH504416A
(de)
|
1966-12-05 |
1971-03-15 |
Ciba Geigy Ag |
Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
|
US4551540A
(en)
|
1983-01-17 |
1985-11-05 |
Borg-Warner Chemicals, Inc. |
Substituted 2,5-dimethylpyrroles
|
US5190541A
(en)
|
1990-10-17 |
1993-03-02 |
Boston Scientific Corporation |
Surgical instrument and method
|
PT627940E
(pt)
|
1992-03-05 |
2003-07-31 |
Univ Texas |
Utilizacao de imunoconjugados para o diagnostico e/ou terapia de tumores vascularizados
|
US5474765A
(en)
|
1992-03-23 |
1995-12-12 |
Ut Sw Medical Ctr At Dallas |
Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
|
US5686472A
(en)
|
1992-10-29 |
1997-11-11 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5593992A
(en)
|
1993-07-16 |
1997-01-14 |
Smithkline Beecham Corporation |
Compounds
|
EP0785937A1
(en)
|
1994-10-14 |
1997-07-30 |
Smithkline Beecham Plc |
2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials
|
CA2216943C
(en)
|
1995-04-19 |
2003-06-17 |
Schneider (Usa) Inc. |
Drug release coated stent
|
US6117432A
(en)
|
1995-04-20 |
2000-09-12 |
Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) |
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
|
TW349948B
(en)
|
1995-10-31 |
1999-01-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 2-quinolone derivatives
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
ATE321757T1
(de)
|
1995-12-08 |
2006-04-15 |
Janssen Pharmaceutica Nv |
(imidazol-5-yl)methyl-2-chinolinonderivate als farnesyl protein transferase inhibitoren
|
US5874442A
(en)
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US5702390A
(en)
|
1996-03-12 |
1997-12-30 |
Ethicon Endo-Surgery, Inc. |
Bioplar cutting and coagulation instrument
|
JPH11514676A
(ja)
|
1996-08-09 |
1999-12-14 |
メルク エンド カンパニー インコーポレーテッド |
立体選択的脱酸素化反応
|
ATE252104T1
(de)
|
1996-12-20 |
2003-11-15 |
Tovarischestvo S Ogranichennoi |
Verfahren und gerät zur herstellung von 1ss, 10ss-epoxy-13-dimethylamino-guaia-3(4)-en-6,12- lid- hydrochlorid
|
UA59384C2
(ru)
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Предотвращение потери костной массы и ее восстановление с помощью агонистов простагландина
|
TW591030B
(en)
|
1997-03-10 |
2004-06-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
|
KR100520401B1
(ko)
|
1997-04-25 |
2005-10-12 |
얀센 파마슈티카 엔.브이. |
파네실 트랜스퍼라제 억제작용을 갖는 퀴나졸리논
|
TW491872B
(en)
|
1997-05-27 |
2002-06-21 |
Ciba Sc Holding Ag |
Block oligomers containing l-hydrocarbyloxy-2,2,6,6-tetramethyl-4- piperidyl groups as stabilizers for lower polyolefin
|
US6100254A
(en)
|
1997-10-10 |
2000-08-08 |
Board Of Regents, The University Of Texas System |
Inhibitors of protein tyrosine kinases
|
DE69902012T2
(de)
|
1998-03-05 |
2002-11-21 |
Formula One Administration Ltd |
Datenübertragungssystem
|
US6303654B1
(en)
|
1998-03-12 |
2001-10-16 |
Wisconsin Alumni Research Foundation |
Acyclic monoterpenoid derivatives
|
WO2000001691A1
(en)
|
1998-07-01 |
2000-01-13 |
Merck & Co., Inc. |
Process for making farnesyl-protein transferase inhibitors
|
EP1097147A4
(en)
|
1998-07-10 |
2001-11-21 |
Merck & Co Inc |
NEW ANGIOGENESIS INHIBITORS
|
PL346426A1
(en)
|
1998-08-27 |
2002-02-11 |
Pfizer Prod Inc |
Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
|
CA2341739C
(en)
|
1998-08-27 |
2005-07-12 |
Pfizer Products Inc. |
Quinolin-2-one derivatives useful as anticancer agents
|
GB9824579D0
(en)
|
1998-11-10 |
1999-01-06 |
Novartis Ag |
Organic compounds
|
SI1140935T1
(en)
|
1998-12-23 |
2003-10-31 |
Janssen Pharmaceutica N.V. |
1,2-annelated quinoline derivatives
|
AU779008C
(en)
|
1999-01-11 |
2005-06-30 |
Princeton University |
High affinity inhibitors for target validation and uses thereof
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
WO2000062778A1
(en)
|
1999-04-15 |
2000-10-26 |
Bristol-Myers Squibb Co. |
Cyclic protein tyrosine kinase inhibitors
|
NZ514918A
(en)
|
1999-04-28 |
2003-11-28 |
Univ Texas |
Compositions and methods for cancer treatment by selectively inhibiting VEGF
|
US6346625B1
(en)
|
1999-06-23 |
2002-02-12 |
Astrazeneca Ab |
Protein kinase inhibitors
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
JP2003519143A
(ja)
|
1999-12-28 |
2003-06-17 |
ファーマコピーア,インコーポレーティッド |
ピリミジン及びトリアジン系キナーゼ阻害剤
|
FR2803592A1
(fr)
|
2000-01-06 |
2001-07-13 |
Aventis Cropscience Sa |
Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
|
US6558385B1
(en)
|
2000-09-22 |
2003-05-06 |
Tissuelink Medical, Inc. |
Fluid-assisted medical device
|
US6692491B1
(en)
|
2000-03-24 |
2004-02-17 |
Scimed Life Systems, Inc. |
Surgical methods and apparatus for positioning a diagnostic or therapeutic element around one or more pulmonary veins or other body structures
|
US6776796B2
(en)
|
2000-05-12 |
2004-08-17 |
Cordis Corportation |
Antiinflammatory drug and delivery device
|
WO2002032861A2
(en)
|
2000-10-17 |
2002-04-25 |
Merck & Co., Inc. |
Orally active salts with tyrosine kinase activity
|
US6958243B2
(en)
*
|
2000-12-14 |
2005-10-25 |
Biotage Ab |
Organic reactions with CO generating materials
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
WO2003024969A1
(en)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
WO2003024931A1
(en)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
TWI259081B
(en)
|
2001-10-26 |
2006-08-01 |
Sugen Inc |
Treatment of acute myeloid leukemia with indolinone compounds
|
CN1582150B
(zh)
|
2001-10-30 |
2011-09-07 |
诺瓦提斯公司 |
作为flt3受体酪氨酸激酶活性抑制剂的星形孢菌素衍生物
|
AU2002360753B2
(en)
|
2001-12-27 |
2008-08-21 |
Theravance, Inc. |
Indolinone derivatives useful as protein kinase inhibitors
|
DE60317198T2
(de)
|
2002-05-23 |
2008-12-04 |
Cytopia Research Pty. Ltd., Richmond |
Proteinkinaseinhibitoren
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
US7304071B2
(en)
|
2002-08-14 |
2007-12-04 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
EP1539754A4
(en)
|
2002-08-23 |
2009-02-25 |
Novartis Vaccines & Diagnostic |
BENZIMIDAZOLE QUINOLINONES AND USES THEREOF
|
AU2003258491A1
(en)
|
2002-09-05 |
2004-03-29 |
Neurosearch A/S |
Amide derivatives and their use as chloride channel blockers
|
BR0315053A
(pt)
|
2002-10-03 |
2005-08-09 |
Targegen Inc |
Agentes vasculostáticos , composição, artigo e processo de preparação dos mesmos
|
EP1566379A4
(en)
|
2002-10-29 |
2005-11-09 |
Kirin Brewery |
QUINOLINE AND QUINAZOLINE DERIVATIVES INHIBITING THE AUTOPHOSPHORYLATION OF FLT3 AND MEDICAL COMPOSITIONS CONTAINING SAME
|
KR20050075005A
(ko)
|
2002-11-13 |
2005-07-19 |
카이론 코포레이션 |
암을 치료하는 방법 및 관련 방법
|
CL2003002353A1
(es)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
DE60326646D1
(de)
|
2002-12-18 |
2009-04-23 |
Vertex Pharma |
Benzisoxazolderivate, die sich als inhibitoren von proteinkinasen eigen
|
WO2004089918A1
(ja)
|
2003-04-09 |
2004-10-21 |
Japan Tobacco Inc. |
複素芳香5員環化合物及びその医薬用途
|
US7429603B2
(en)
|
2003-04-25 |
2008-09-30 |
3-Dimensional Pharmaceuticals, Inc. |
C-fms kinase inhibitors
|
US7427683B2
(en)
*
|
2003-04-25 |
2008-09-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
c-fms kinase inhibitors
|
US20050113566A1
(en)
|
2003-04-25 |
2005-05-26 |
Player Mark R. |
Inhibitors of C-FMS kinase
|
US7790724B2
(en)
|
2003-04-25 |
2010-09-07 |
Janssen Pharmaceutica N.V. |
c-fms kinase inhibitors
|
MXPA06001094A
(es)
|
2003-07-28 |
2006-04-11 |
Smithkline Beecham Corp |
Compuestos quimicos.
|
CN1950347B
(zh)
|
2003-10-23 |
2012-04-04 |
Ab科学公司 |
作为酪氨酸激酶抑制剂的2-氨基芳基噁唑化合物
|
GB0326601D0
(en)
|
2003-11-14 |
2003-12-17 |
Novartis Ag |
Organic compounds
|
CN1934107A
(zh)
|
2004-01-30 |
2007-03-21 |
Ab科学公司 |
作为酪氨酸激酶抑制剂的2-(3-取代芳基)氨基-4-芳基-噻唑
|
AU2005299501B2
(en)
*
|
2004-10-22 |
2011-03-03 |
Janssen Pharmaceutica N.V. |
Aromatic amides as inhibitors of c-fms kinase
|
US7645755B2
(en)
|
2004-10-22 |
2010-01-12 |
Janssen Pharmaceutical N.V. |
Inhibitors of c-fms kinase
|
US7662837B2
(en)
|
2004-10-22 |
2010-02-16 |
Janssen Pharmaceutica N.V. |
Inhibitors of c-fms kinase
|
HUE033089T2
(en)
|
2004-10-22 |
2017-11-28 |
Janssen Pharmaceutica Nv |
C-FMS kinase inhibitors
|
US20060281771A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminoquinoline and aminoquinazoline kinase modulators
|
US20060281788A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
|
US20060281769A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators
|
US20060281700A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
US20060281755A1
(en)
|
2005-06-10 |
2006-12-14 |
Baumann Christian A |
Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators
|
NZ595182A
(en)
|
2005-10-18 |
2012-12-21 |
Janssen Pharmaceutica Nv |
Pharmaceutical uses of 4-cyano-1H-imidazole-2-carboxylic acid { 2-cyclohex-1-enyl-4-[1-(2-dimethylamino-acetyl)-piperidin-4-yl]-phenyl} -amide
|
UA93085C2
(en)
|
2006-04-20 |
2011-01-10 |
Янссен Фармацевтика Н.В. |
Inhibitors of c-fms kinase
|
US8697716B2
(en)
|
2006-04-20 |
2014-04-15 |
Janssen Pharmaceutica Nv |
Method of inhibiting C-KIT kinase
|
EP2021335B1
(en)
|
2006-04-20 |
2011-05-25 |
Janssen Pharmaceutica N.V. |
Heterocyclic compounds as inhibitors of c-fms kinase
|
JP5480619B2
(ja)
|
2006-04-20 |
2014-04-23 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
c−fmsキナーゼの阻害剤
|
CN101631786A
(zh)
*
|
2006-12-20 |
2010-01-20 |
先灵公司 |
新颖的jnk抑制剂
|
WO2008138184A1
(fr)
*
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co.Ltd. |
Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
|
JO3240B1
(ar)
|
2007-10-17 |
2018-03-08 |
Janssen Pharmaceutica Nv |
c-fms مثبطات كيناز
|
EP2215482A2
(en)
|
2007-10-31 |
2010-08-11 |
Janssen Pharmaceutica N.V. |
Biomarker for assessing response to fms treatment
|
US20120040951A1
(en)
*
|
2008-12-30 |
2012-02-16 |
Claudio Chuaqui |
Heteroaryl compounds useful as raf kinase inhibitors
|
JP2011026305A
(ja)
*
|
2009-06-24 |
2011-02-10 |
Daiichi Sankyo Co Ltd |
イミダゾールカルボニル化合物を含有する医薬組成物
|
NZ597833A
(en)
*
|
2009-09-28 |
2014-01-31 |
Hoffmann La Roche |
Benzoxazepin pi3k inhibitor compounds and methods of use
|
WO2011090935A1
(en)
*
|
2010-01-19 |
2011-07-28 |
Merck Sharp & Dohme Corp. |
PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
|
JP6359537B2
(ja)
*
|
2012-08-07 |
2018-07-18 |
ヤンセン ファーマシューティカ エヌ.ベー. |
複素環エステル誘導体の調製プロセス
|